[{"AccountsPayableCurrent_0_Q1_USD":18236000.0,"LongTermDebtCurrent_0_Q1_USD":10734000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":906000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-65835000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":106536000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":2000.0,"OtherAssetsNoncurrent_0_Q1_USD":1553000.0,"LongTermDebtNoncurrent_0_Q1_USD":234488000.0,"Goodwill_0_Q1_USD":44543000.0,"EarningsPerShareBasic_1_Q1_USD":-0.63,"CostOfGoodsAndServicesSold_1_Q1_USD":568000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":54777000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":958000.0,"InventoryWorkInProcess_0_Q1_USD":1117000.0,"InventoryRawMaterials_0_Q1_USD":2218000.0,"InventoryGross_0_Q1_USD":4147000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-96000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":321000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":812000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":776000.0,"TreasuryStockShares_0_Q1_shares":741000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":8000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":76000000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q1_USD":2200000.0,"DebtInstrumentFairValue_0_Q1_USD":55200000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":55592000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":362000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":4432000.0,"RealizedInvestmentGainsLosses_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":15137000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":923000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":19275000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-102000.0,"ShortTermInvestments_0_Q1_USD":193545000.0,"PaymentsToAcquireInvestments_1_Q1_USD":33222000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":249137000.0,"OtherAssetsCurrent_0_Q1_USD":8195000.0,"AvailableForSaleSecurities_0_Q1_USD":193545000.0,"TreasuryStockValue_0_Q1_USD":4740000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":983000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":61302000.0,"ShareBasedCompensation_1_Q1_USD":4432000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":55181000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-22054000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":42778000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-1244000.0,"LiabilitiesCurrent_0_Q1_USD":80319000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":370567000.0,"Liabilities_0_Q1_USD":315790000.0,"InventoryNet_0_Q1_USD":4147000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2875000.0,"NetIncomeLoss_1_Q1_USD":-66611000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-26397000.0,"CommonStockSharesIssued_0_Q1_shares":107711000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":19480000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":55592000.0,"AssetsCurrent_0_Q1_USD":291614000.0,"Assets_0_Q1_USD":370567000.0,"AdditionalPaidInCapital_0_Q1_USD":1466604000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":860000.0,"AccountsReceivableNetCurrent_0_Q1_USD":30135000.0,"CommonStockValue_0_Q1_USD":108000.0,"RoyaltyIncomeNonoperating_1_Q1_USD":114000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":0.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1408055000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":923000.0,"OperatingIncomeLoss_1_Q1_USD":-62438000.0,"OperatingExpenses_1_Q1_USD":70437000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":13582000.0,"InterestPaidNet_1_Q1_USD":3658000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":5444000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q1_pure":0.09,"CommonStockSharesAuthorized_0_Q1_shares":225000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":51349000.0,"StockholdersEquity_0_Q1_USD":54777000.0,"Revenues_1_Q1_USD":7999000.0,"InterestExpense_1_Q1_USD":5131000.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":800000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200427"}]